ES2053014T3 - El retrovirus siv cpz-ant y sus usos. - Google Patents

El retrovirus siv cpz-ant y sus usos.

Info

Publication number
ES2053014T3
ES2053014T3 ES90111364T ES90111364T ES2053014T3 ES 2053014 T3 ES2053014 T3 ES 2053014T3 ES 90111364 T ES90111364 T ES 90111364T ES 90111364 T ES90111364 T ES 90111364T ES 2053014 T3 ES2053014 T3 ES 2053014T3
Authority
ES
Spain
Prior art keywords
ant
lymphocytes
hiv
west
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90111364T
Other languages
English (en)
Other versions
ES2053014T5 (es
Inventor
Peter Prof Dr Piot
Der Groen Guido Dr Sc Van
Eric Dr Delaporte
Martine Dr Peeters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8204103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2053014(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Publication of ES2053014T3 publication Critical patent/ES2053014T3/es
Application granted granted Critical
Publication of ES2053014T5 publication Critical patent/ES2053014T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION ACTUAL SE REFIERE A UN RETROVIRUS AISLADO DE UN CHIMPACE Y DESIGNADO COMO SIV SUB CPZ-ANT Y A LAS VARIANTES DE ESTE VIRUS, PROVISTO DE LAS SIGUIENTES PROPIEDADES ESENCIALES MORFOLOGICAS E INMUNOLOGICAS: PARA T4 LINFOCITOS. TIPICO CON LA FORMACION DE CELULAS GIGANTES EN LOS LINFOCITOS QUE INFECTA, NM, PTASA DEPENDIENTE DEL MAGNESIO, ELULARES INMORTALIZADAS PORTADORAS DEL RECEPTOR T4, DOS DEL VIRUS CONTIENEN UNA PROTEINA P27 DISTINTA INMUNOLOGICAMENTE DE LA P25 DEL HIV-1 Y DE LA PROTEINA P19 DEL HTLV-1 SEGUN LOS ANALISIS DE MANCHAS DEL OESTE, NTIENEN UNA PROTEINA GP140 INMUNOLOGICAMENTE DISTINTA DE LA GP120 DEL HIV-1 Y DE LA GP110 DEL HTLV-1 SEGUN LOS ANALISIS DE MANCHAS DEL OESTE, UNA GLICOPROTEINA TRANSMEMBRANOSA CON UN PESO MOLECULAR DE 44.000 A 50.000 KD.
ES90111364T 1990-06-15 1990-06-15 El retrovirus sivcpz-ant y sus usos. Expired - Lifetime ES2053014T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90111364A EP0494317B2 (en) 1990-06-15 1990-06-15 The retrovirus SIV cpz-ant and its uses

Publications (2)

Publication Number Publication Date
ES2053014T3 true ES2053014T3 (es) 1994-07-16
ES2053014T5 ES2053014T5 (es) 2001-02-16

Family

ID=8204103

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90111364T Expired - Lifetime ES2053014T5 (es) 1990-06-15 1990-06-15 El retrovirus sivcpz-ant y sus usos.

Country Status (10)

Country Link
US (1) US5624795A (es)
EP (1) EP0494317B2 (es)
JP (1) JPH06500230A (es)
AT (1) ATE105857T1 (es)
AU (1) AU657479B2 (es)
CA (1) CA2085370A1 (es)
DE (1) DE69009066T3 (es)
DK (1) DK0494317T4 (es)
ES (1) ES2053014T5 (es)
WO (1) WO1991019785A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470572A (en) * 1993-07-16 1995-11-28 University Of Puerto Rico Non-infectious simian immunodeficiency virus particles produced by cell line CRL 11393
WO2003062377A2 (en) * 2002-01-17 2003-07-31 The Uab Research Foundation COMPLETE GENOME SEQUENCE OF SIVcpzTAN1
CN102985536B (zh) 2010-04-14 2017-12-05 Emd密理博公司 生产高效价、高纯度的病毒母液的方法及使用其的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64006B1 (en) † 1984-10-18 1995-06-28 Pasteur Institut Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus
ES2150897T3 (es) † 1986-01-22 2000-12-16 Pasteur Institut Procedimiento de fabricacion recombinante de las proteinas derivadas de hiv-2 y cultivo celular que expresa proteinas de hiv-2.
WO1989009815A1 (en) * 1988-04-04 1989-10-19 Research Corporation Technologies, Inc. Novel virus of the hiv-2 family and methods of detection therefor
EP0345375B1 (en) * 1988-06-09 1995-03-22 N.V. Innogenetics S.A. HIV-3 retrovirus and its use
FR2644176B1 (fr) † 1989-03-07 1993-10-08 Franceville Ctre Internal Recher Retrovirus viscpz infectant naturellement le chimpanze, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou d'une enzyme de ce virus et leurs utilisations

Also Published As

Publication number Publication date
WO1991019785A1 (en) 1991-12-26
EP0494317A1 (en) 1992-07-15
EP0494317B2 (en) 2000-12-27
DE69009066T3 (de) 2001-07-19
US5624795A (en) 1997-04-29
EP0494317B1 (en) 1994-05-18
CA2085370A1 (en) 1991-12-16
ES2053014T5 (es) 2001-02-16
DE69009066T2 (de) 1994-10-06
AU7967091A (en) 1992-01-07
DK0494317T4 (da) 2001-04-02
AU657479B2 (en) 1995-03-16
ATE105857T1 (de) 1994-06-15
DE69009066D1 (de) 1994-06-23
JPH06500230A (ja) 1994-01-13
DK0494317T3 (da) 1994-10-10

Similar Documents

Publication Publication Date Title
Pique et al. Pathways of cell-cell transmission of HTLV-1
Guyader et al. Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization
Burns et al. Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence
ES2126620T3 (es) Retrovirus del grupo de los vih y su utilizacion.
CY1107760T1 (el) Κυτταρα φακοϊικου εγκλεισμου
FI903866A0 (fi) Terapeutiskt aktiva albuminderivat.
DK1402015T3 (da) Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein og FkpA eller SlyD
Beatty et al. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction
EA200300336A1 (ru) Пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
Ikuta et al. Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens
ATE116658T1 (de) Testverfahren zum nachweis von menschlichem lymphotropischem virus.
Costa et al. Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1
PE43298A1 (es) Genes sinteticos de vih
Simon et al. Vif and the p55Gag polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
ATE135743T1 (de) Monoklonale menschliche antikörper gegen hiv-i
ES2053014T3 (es) El retrovirus siv cpz-ant y sus usos.
Dirckx et al. Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity
Berkower et al. A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoprotein gp120
ES2058259T3 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
ES2074591T3 (es) Expresion de polipeptidos de vih 1 y 2 y su utilizacion.
Cloyd et al. Heterogeneity of human immunodeficiency virus cell-associated antigens and demonstration of virus type specificities of human antibody responses
ES2195200T3 (es) Construccion de peptidos de rama multiples.
Hunsmann Subunit vaccines against exogenous retroviruses: overview and perspectives
ES2113860T3 (es) Peptidos con grupos tioles de cisteina protegidos, utiles en los ensayos inmunologicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 494317

Country of ref document: ES